Morgan Stanley lowered the firm’s price target on Arm (ARM) to $171 from $180 and keeps an Overweight rating on the shares. The firm expects licensing and royalties to support Q2 earnings and sees an “attractive entry point” given what it sees as Arm’s long-term prospects for custom chip development and core business growth. However, the firm lowered its price target due to estimate changes in FY27, the analyst noted.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARM:
- Corning appoints Arm CMO Ami Badani to board of directors
- Berkshire to acquire OxyChem, OpenAI reaches $500B valuation: Morning Buzz
- Qualcomm chips adopt latest generation of Arm technology, Reuters reports
- Arm Holdings PLC call volume above normal and directionally bullish
- Qualcomm’s Stock (QCOM) Down amid Report Its Premium Chips Will Use Arm’s Latest Technology